The monoclonal antibody Itolizumab received authorization to start a phase III clinical trial in Covid-19 patients in the US, Mexico and Brazil, reported on Wednesday Cuba's Center for Molecular Immunology (CIM).
Read more Cuba's medicine will be tested in the US, Mexico and Brazil
HeberFERON, a drug developed by the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym) for the treatment of skin cancer, could become another therapeutic alternative for diseases such as brain tumors and renal carcinomas.
Read more Cuban experts test HeberFERON in treatment of brain tumors and kidney cancer
Statement by the Ministry of Foreign Affairs
The U.S. government once again discredits itself by unjustly including Cuba on the List of countries that “do not fully cooperate with its anti-terrorism efforts”.
Read more Repeating a Lie Doesn’t Make It True: Cuba does not support terrorism
Photos: Juan Pablo Carreras / ACN
With the world premiere of "Sentimientos. Odisea de la mente," in collaboration with Austrian choreographer Mike Loewenrosen, the Holguín dance company Codanza returns to stages on April 25, 26, and 27.
Read more Codanza to Premiere “Sentimientos” in Holguín
The University of Holguín expands the distance postgraduate studies to facilitate the growth of scientific potential in Cuba and other countries interested in drawing on the training process from the institution.
Read more University of Holguín expands distance postgraduate studiesMore Articles
Page 377 of 504